KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM, L3
Market cap: $66.5M (2/09/2026)
Price: $1.45
Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones
Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
Announces Second Quarter 2025 Financial Results and Business Updates
Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis
Shareholder votes
Annual Report to Security Holders
Financial Results, Reg. FD
Announces Full Year 2024 Financial Results and Provides Business Updates
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
PRER14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload